Clinical trial
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT00290563 · Vyne Therapeutics Inc., Industry · Completed
Key facts
| NCT number | NCT00290563 |
|---|---|
| Title | Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK0594 in Patients With Overactive Bladder |
| Lead sponsor | Vyne Therapeutics Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Overactive Bladder |
| Intervention type | Drug |
| Interventions | MK0594 |
| Enrollment | 557 |
| Start date | Feb 21, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 24, 2007 |
| First posted | Feb 13, 2006 |
| Last update posted | May 19, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: